Emerging From the Haze for Gynecologic Cancer Survivors

Status Completed

Clinical Trial Summary

At Cedars-Sinai Medical Center, the investigators have developed a novel curriculum for a 6-week psycho-educationally-based, cognitive behavioral program to help patients with subjective cognitive complaints after cancer treatment, titled Emerging from the Haze™ (Haze). Each series meets once a week for 2-2.5 hours for 6 weeks.

The objective of this study is to quantify the impact of a trainee-taught Emerging from the Haze course on gynecologic cancer survivors' self-report of cognitive changes based on the change of FACT-Cog score.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02918461
Study type	Interventional
Source	Cedars-Sinai Medical Center
Contact
Status	Completed
Phase	N/A
Start date	January 10, 2017
Completion date	November 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02488720` - Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Recruiting	`NCT03544801` - Renji Cerebral Small Vessel Disease Corhort Study
Recruiting	`NCT02813434` - Cerebral Amyloid Imaging Using Florbetapir (AV-45)	Phase 3
Completed	`NCT00400790` - Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane	N/A
Completed	`NCT00052091` - Therapy for Depressed Elders With Thought Problems	Phase 3
Completed	`NCT00267163` - Brain Imaging and Mental Disorders of Aging Intervention	Phase 4
Completed	`NCT00021866` - Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy	N/A
Not yet recruiting	`NCT04079075` - Multiple Interventions to Prevent Cognitive Decline	N/A
Terminated	`NCT03696082` - A Precision Rehabilitation Approach to Counteract Age-Related Cognitive Declines	N/A
Completed	`NCT02918539` - Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
Active, not recruiting	`NCT01708837` - Effect of Depth of Total Intravenous Anesthesia Using Propofol on Postoperative Cognitive Dysfunction	Phase 4
Completed	`NCT01290939` - Bevacizumab and Lomustine for Recurrent GBM	Phase 3
Terminated	`NCT00548327` - The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype	Phase 2
Unknown status	`NCT00256425` - Cognitive Rehabilitation of Glioma Patients	Phase 3
Recruiting	`NCT03926351` - High Dose Omega 3 in People at Risk for Dementia	Phase 2
Completed	`NCT02118571` - Schizophrenia Cognition Scale Development	N/A
Completed	`NCT01481961` - Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as add-on Treatment for Early Alzheimer's Disease	N/A
Completed	`NCT00788918` - Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)	N/A
Completed	`NCT00564902` - The Zeaxanthin and Visual Function Study	N/A
Completed	`NCT00529581` - A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis	Phase 2